Literature DB >> 1405601

Treatment of experimental liver metastases with a noncontact neodymium: YAG laser.

R Van Hillegersberg1, W J Kort, M Vermeij, O T Terpstra.   

Abstract

The extent of tumor and liver damage after treatment with the neodymium:yttrium-aluminum-garnet (Nd:YAG) laser was investigated in a rat tumor model. Colon carcinoma CC531 was implanted in the liver and treated with 60 J (14 tumors), 120 J (15 tumors), or 180 J (12 tumors) at a power setting of 20 W. To assess the effects upon the tissues three animals were sacrificed immediately after treatment and 1, 2, 4, and 8 days later. Sections from the tumor sites were evaluated by light microscopy and the maximal depth and width of different zones of tissue damage were measured. Laser effects could be determined most accurately on Days 1 and 2 after treatment. Multiple linear regression analysis of the data indicated a linear relationship between laser energy and depth of tumor damage (P less than 0.01). The results of this study show the potential of the Nd:YAG laser to produce tumor coagulation necrosis with minimal liver necrosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1405601     DOI: 10.1016/0022-4804(92)90024-t

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  The Nd:YAG LIMAX® 120 high-output laser: local effects and resection capacity on liver parenchyma.

Authors:  Andreas Kirschbaum; P Rexin; D K Bartsch; P Di Fazio
Journal:  Lasers Med Sci       Date:  2014-02-22       Impact factor: 3.161

2.  A new liver-tumor model in the rat.

Authors:  J D Nagel; W J Kort
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 3.  Mouse models of colorectal cancer.

Authors:  Yunguang Tong; Wancai Yang; H Phillip Koeffler
Journal:  Chin J Cancer       Date:  2011-07

4.  Interstitial photodynamic therapy in a rat liver metastasis model.

Authors:  R van Hillegersberg; J P Marijnissen; W J Kort; P E Zondervan; O T Terpstra; W M Star
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.